These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Further characterization of alpha N-acetyl beta-endorphin-(1-31) regulatory activity, I: Effect on opioid- and alpha 2-mediated supraspinal antinociception in mice. Sánchez-Blázquez P; Garzón J Life Sci; 1992; 50(26):2083-97. PubMed ID: 1318989 [TBL] [Abstract][Full Text] [Related]
23. Brain passage of BUBU, a highly selective and potent agonist for delta opioid receptors: in vivo binding and mu versus delta receptors occupancy. Delay-Goyet P; Ruiz-Gayo M; Baamonde A; Gacel G; Morgat JL; Roques BP Pharmacol Biochem Behav; 1991 Jan; 38(1):155-62. PubMed ID: 1850135 [TBL] [Abstract][Full Text] [Related]
24. Effects of antisense oligonucleotides on brain delta-opioid receptor density and on SNC80-induced locomotor stimulation and colonic transit inhibition in rats. Negri L; Broccardo M; Lattanzi R; Melchiorri P Br J Pharmacol; 1999 Dec; 128(7):1554-60. PubMed ID: 10602336 [TBL] [Abstract][Full Text] [Related]
25. Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the delta non-complexed-opioid receptor. Mattia A; Vanderah T; Mosberg HI; Omnaas JR; Bowen WD; Porreca F Eur J Pharmacol; 1991 Jan; 192(3):371-5. PubMed ID: 1647317 [TBL] [Abstract][Full Text] [Related]
26. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone. Crain SM; Shen KF Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459 [TBL] [Abstract][Full Text] [Related]
29. Opioid receptor involvement in food deprivation-induced feeding: evaluation of selective antagonist and antisense oligodeoxynucleotide probe effects in mice and rats. Hadjimarkou MM; Singh A; Kandov Y; Israel Y; Pan YX; Rossi GC; Pasternak GW; Bodnar RJ J Pharmacol Exp Ther; 2004 Dec; 311(3):1188-202. PubMed ID: 15333676 [TBL] [Abstract][Full Text] [Related]
30. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse. Tseng LF; Collins KA J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973 [TBL] [Abstract][Full Text] [Related]
31. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse. Vaught JL; Mathiasen JR; Raffa RB J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533 [TBL] [Abstract][Full Text] [Related]
32. Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Davenport KE; Houdi AA; Van Loon GR Neurosci Lett; 1990 May; 113(1):40-6. PubMed ID: 2164174 [TBL] [Abstract][Full Text] [Related]
33. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice. Suh HH; Tseng LF J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954 [TBL] [Abstract][Full Text] [Related]
35. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse. Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674 [TBL] [Abstract][Full Text] [Related]
36. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice. Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986 [TBL] [Abstract][Full Text] [Related]
37. The role of the G protein gamma(2) subunit in opioid antinociception in mice. Hosohata K; Logan JK; Varga E; Burkey TH; Vanderah TW; Porreca F; Hruby VJ; Roeske WR; Yamamura HI Eur J Pharmacol; 2000 Mar; 392(3):R9-R11. PubMed ID: 10762674 [TBL] [Abstract][Full Text] [Related]
38. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Bodnar RJ; Williams CL; Lee SJ; Pasternak GW Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129 [TBL] [Abstract][Full Text] [Related]
39. Differentiation of mu- and kappa-receptors by means of correlation of analgesic potency in vivo and receptor binding affinity in vitro of various opioid agonists. Ensinger HA; Stockhaus K; Merz H Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):649-53. PubMed ID: 6096651 [TBL] [Abstract][Full Text] [Related]
40. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Garzón J; Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P Psychopharmacology (Berl); 2005 Jun; 180(1):1-11. PubMed ID: 15830230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]